Comera Life Sciences Inc...
(CMRA)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY22 | FY21 | FY20 |
| Revenue | 633.10K | 319.83K | 442.92K |
| Cost of Revenue | 210.39K | 161.01K | 104.41K |
| Gross Profit | 422.71K | 158.82K | 338.51K |
| Operating Income | -11.97M | -5.54M | -2.13M |
| Interest Income | n/a | n/a | n/a |
| Pretax Income | -18.00M | -5.45M | -2.13M |
| Net Income | -18.00M | -5.29M | -2.13M |
| Selling & General & Admin | 10.65M | 3.94M | 1.20M |
| Research & Development | 1.74M | 1.75M | 1.26M |
| Other Expenses | n/a | -76.74K | 2.03K |
| Operating Expenses | 12.39M | 5.69M | 2.47M |
| Interest Expense | 20.39K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a |
| Cost & Expenses | 12.60M | 5.86M | 2.57M |
| Income Tax | n/a | -160.59K | -116.55K |
| Shares Outstanding (Basic) | 10.45M | 19.09M | 19.09M |
| Shares Outstanding (Diluted) | 10.45M | 19.09M | 19.09M |
| EPS (Basic) | -1.76 | -0.28 | -0.11 |
| EPS (Diluted) | -1.76 | -0.28 | -0.11 |
| EBITDA | -17.89M | -5.36M | -2.04M |
| Depreciation & Amortization | 93.95K | 88.82K | 89.75K |